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ABSTRACT
We describe the case of a woman with minimal glomerular changes on initial kidney biopsy. On long-term follow-up, the
patient developed nephrotic proteinuria and a second kidney biopsy was performed, which revealed focal segmental
glomerulosclerosis (FSGS). Findings from electron microscopy (EM) examination suggested a genetic form of FSGS. Next-
generation sequencing showed heterozygosity for a mutation in COL4A3. Collagen IV nephropathies can be linked to late-
onset FSGS. By establishing a genetic cause of FSGS, immunosuppressive treatment can be avoided. This case emphasizes
the importance of re-biopsy in cases of a non-explained rise in proteinuria. EM can be helpful in differentiating between
primary and secondary FSGS and informing treatment strategies. In cases of adult-onset FSGS that cannot be categorized by
clinical–pathological assessment, genetic testing should be considered.
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CASE DESCRIPTION
A 41-year-old woman, with a previous history of microscopic
haematuria since childhood, was referred for persistent protein-
uria that began since January 2006, following a second preg-
nancy complicated by pre-eclampsia (Supplementary data,
Figure S1).
With proteinuria reaching >1 g/24 h, an initial kidney biopsy
was performed in December 2007, which showed minimal glo-
merular changes on light microscopy (LM) examination.
Electron microscopy (EM) revealed features of diffuse podocyte
foot process effacement (FPE), and no changes were observed in
the glomerular basement membrane (GBM) (Figure 1A). A non-
immuno-suppressive treatment regimen, comprising an
angiotensin-converting enzyme inhibitor (ACEi), a statin and a
nephroprotective diet, was initiated.
Over the next 10 years following the above treatment, the
patient remained clinically stable with no hypertension or oe-
dema. Biochemical parameters were maintained within the
normal range, with an estimated glomerular filtration rate of
> 90 mL/min and proteinuria of <1.5 g/24 h.
At the end of 2017, the patient developed nephrotic-range
proteinuria, in the absence of nephrotic syndrome, without any
obvious trigger. A second kidney biopsy was performed, and
both light microscopy (LM) and immunofluorescence examina-
tion revealed characteristic pathological features leading to a di-
agnosis of focal segmental glomerulosclerosis (FSGS).
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On EM examination, there was 100% podocyte FPE, and the
GBM showed splitting of the lamina densa (Figure 1B). Foamy
cells were seen, which were also observed in the first biopsy
(Supplementary data, Figure S2).
Our patient showed no clinical features of Alport syndrome
and did not have any family history of kidney disease. However,
as lamina densa splitting is diagnostic of Alport syndrome,
next-generation sequencing (NGS) was performed (Supplemen-
tary data, Table S1), which showed heterozygosity for a patho-
genic mutation in the COL4A3 gene. The presence of a
heterozygous mutation in COL4A3 is usually associated with an
autosomal dominant form of microscopic haematuria. Collagen
IV nephropathy shows considerable heterogeneity, and a domi-
nant form of progressive FSGS has been described in some fami-
lies [1–4].
Immunosuppressive treatment is not appropriate in the
management of genetic forms of FSGS, and non-immuno-
suppressive measures have to be continued life-long. Genetic
testing with NGS is recommended in all first-degree relatives
[3–5]. In our present case, NGS was performed, which revealed
the same mutation in the patient’s father in the absence of clin-
ical or biochemical signs.
DISCUSSION
This case emphasizes the importance of the quality and timing
of kidney biopsy [5].
Adequate biopsy sampling is essential for tissue detection of
FSGS. Furthermore, timing of the biopsy with respect to the dis-
ease course is important. The initial pathological changes of
podocyte FPE are only detectable by EM, because the character-
istic sclerotic lesions take time to develop.
Findings on LM examination are rarely pathognomonic for
particular forms of FSGS. The major ultrastructural finding on
EM is FPE [3, 5], which can help distinguish between primary
and secondary forms of FSGS. Although diffuse FPE is not a de-
fining signature of primary FSGS, it eliminates maladaptive sec-
ondary mechanisms as the cause of the FSGS lesions. A genetic
form of FSGS must be considered when either diffuse or
segmental FPE is observed. EM can help to identify FSGS as
a manifestation of the expanding spectrum of collagen IV
nephropathies [1–3, 5] by revealing an irregular thickening of
the GBM with splitting of the lamina densa.
Collagen IV nephropathies comprise benign familial micro-
scopic haematuria, thin basement membrane nephropathy, X-
linked Alport syndrome and also autosomal recessive and dom-
inant Alport syndrome. Apart from the X-linked form of Alport
syndrome, which is caused by hemizygous mutations in the
COL4A5 gene, the other entities are caused by mutations in the
COL4A3 or COL4A4 genes [1–4].
The spectrum of collagen IV nephropathies [1–5] is broad
and expanding rapidly and, more recently, has included late-
onset FSGS, which develops alongside thin basement mem-
brane nephropathy in later life, as described here. At one end,
we find phenotypes of benign familial microscopic haematuria,
while intermediate phenotypes are also present and can evolve
progressively towards end-stage renal disease in later life.
Deltas et al. [1] and Ars and Torra [4] hypothesize that the
full spectrum of phenotypes in heterozygous collagen IV muta-
tion carriers behaves as a multifactorial condition that impli-
cates the primary genes, modifier genes and environmental
factors. Such wide phenotypic heterogeneity, when accompa-
nied by incomplete presentation of certain signs and symptoms
and sometimes also by a lack of detailed histology, including
EM, can lead to misdiagnosis, in turn resulting in possibly inef-
fective and potentially toxic treatments with immunosuppres-
sive agents [3–5].
Long-term follow-up during the course of ageing is manda-
tory to reveal the entire phenotypic spectrum, as there is a clear
age-dependent penetrance. Most likely progression to FSGS and
chronic renal failure will only present in late adult life and
mostly after 40 years of age [1, 3, 5].
At the same time, this variable expressivity is evidently
influenced by the genetic background of each patient and envi-
ronmental factors. The mechanisms that underlie the develop-
ment of FSGS and severe renal failure as a result of inheritance
of a heterozygous COL4A mutation are largely unknown [1, 4].
It is important to recommend referral for genetic testing for
all first-degree relatives of patients who are found to have a
COL4A3/A4 mutation [1–3, 5]. In cases of positivity, long-term
follow-up and preventive measures are mandatory.
Management of proteinuria with ACEis or angiotensin receptor
blockers, as well as a nephroprotective diet, can delay disease
FIGURE 1. (A) Ultrastructural alterations of the 1st biopsy: Diffuse effacement of the foot processes is present (FP). No deposition of electrondense proteins nor changes
at the basement membrane are observed. Although some segments of basement membrane might appear thin (arrow), they measure 272 nm, which is within normal
limits (adult female 3206 50 nm). (3000). (B) Ultrastructural alterations of the 2nd biopsy: Splitting of the lamina densa is observed (arrow), resulting in irregular thick-
ening and contouring of the glomerular basement membrane. The foot processes (FP) are effaced. (7000).
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progression and influence renal outcomes [3, 5]. In addition, rec-
ognizing that a patient has a genetic form of FSGS will have an
impact on selecting of a living-related kidney donor and renal
transplantation success. Furthermore, there is a substantially
lower risk of recurrence of genetic forms of FSGS following
transplantation, compared with primary FSGS [3].
SUPPLEMENTARY DATA
Supplementary data are available at ckj online.
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